Medical Advisor/(Associate) Medical Affairs Manager - CVRM - HCM

Job Description / Capsule

An external and internal facing role that provides medical and clinical expertise in priority therapeutic areas and builds AZ scientific leadership. The role focuses on the development of professional relationships with OLs, building deep scientific understanding of AstraZeneca compounds by engaging OLs in ESRs, scientific exchange meetings and advisory board meetings. In addition the Medical Advisor will input into Brand Strategy and LCM and take the lead in the design and implementation of medical activities aligned with Brand Strategy. Further internal accountabilities include  the delivery of  medical education and clinical support to medical professionals, training sales teams and involvement in development of brand strategy.

May take responsibility as Nominated Signatory reviewer for activities and promotional materials. May take responsibility for mentorship of MSL/s in the country. May lead Medical Information and Pharmacovigilance within a particular market.

External Medical & Scientific engagement 

1/ Build, enhance and maintain the engagement with scientific leaders (OLs).

• 50% of time in field engaging  HCPs and key  external stakeholders engagement

• Proactively identify HCPs with high levels of  scientific expertise in local treatment practice to collaborate on specific medico marketing activities
• Development and implementation of OL engagement plan in collaboration with line manager and TA lead..

• Develop database of Key opinion leaders and also provide recommendations for advisory board participation, potential speakers and train speakers as appropriate.

• Develop own scientific knowledge and share emerging data with HCPs, discussing all aspects of the data in a scientific, objective and balanced way. Disseminate results of studies completed to medical community by translating their clinical values and incorporating into business strategies.
• Respond to unsolicited requests for information about unapproved AZ products or unapproved uses of approved products, presenting such information in an objective, scientifically balanced, substantiated manner.

Measures (QQA) 

Quantity

• 50% of available time spent meeting OLs. (Available time = total days minus, holidays, weekends, sickness)
• Coverage of OLs versus plan
• No of Advisory Board Meetings versus plan
• No of P2Ps/round table discussions versus plan
• No of CMEs versus plan
• Improvement in advocacy score as reviewed by line manager1:1

Quality

• Meeting skills and presentation skills based on in field coaching and annual role play assessment – use standard assessment form
• Positive customer feedback post events

2/ Develop or initiate scientific programs to explore unmet medical needs in priority disease area(s)

• Discuss potential involvement in ESR and RWEs. Interact in the field with KOLs for clinical trials, , ESRs
• Able to conduct basic discussions on clinical trials in terms of study design and feasibility

Measures (QQA)

Quantity

• No of ESRs communicated

Quality

• Customer feedback
• In field observation by line manager and coaching form

Medical & Scientific Support for internal stakeholders

1/ To establish AstraZeneca as a scientific leader through proactive, updated and effective Medical input

• Provide the AZ internal stakeholders with an understanding of the local medical community, clinical practice, trends and real or perceived gaps in current scientific knowledge and medical treatment, competitive intelligence
• Provide medical input for the development of company’s Brand plans
• Develop and implement the local medical plan to address unmet medical needs in priority disease areas and ensure alignment with the brand plan.
• Develop and implement pre-launch medical plan/activities for new products at least 2 years prior to the planned launch in the country to address key clinical and scientific challenges
• Provide medical leadership on faculty and content development for medical programmes including national congresses, advisory boards, scientific exchange meetings, publications, CMEs to meet identified needs
• Provide medical input to global protocols, study feasibility and local customer’s research initiatives.

Measures (QQA)

Quantity

• % of trainings conducted versus plan

Quality

• Feedback from participants
• Feedback from business partners on quality of contribution to Medical and Brand plans – collected by line manager
• Feedback on congress report/highlights shared with cross-functional team as planned – completed feedback templates

2/ Provide medical input into the Life Cycle Management of priority brands and TAs to meet unmet medical needs

• Participate as key member of brand team as strategic partner towards LCM actions
• Develop NIS or registry studies to address unmet medical needs
• Initiate discussions with customers to develop studies that will fulfil global and local business strategies.

Measures (QQA)

• ESR Proposals- Number
• For NIS number of sites, KOLs, investigators involved in studies versus plan
• Timely publications of studies completed

3/ Governance and ensuring overall adherence to processes and regulation [include but not limit to patient safety, clinical trials, promotional activities, etc…]

• Provide medical input to the creation, development and agreement of promotional material and ensure all material is in line with internal SOPs and meets IFPMA code
• Support Clinical team to select appropriate investigators and sites optimising quality, delivery and commercial benefit
• Ensures compliance with AZ code of conduct, Corporate Governance, Audits requirement, guidelines, codes, policies and procedures
• Ensures that company confidentiality is maintained (i.e. intellectual property, product, strategic and salary information)
• Discloses potential breach of codes or conducts

Measures (QQA)

• Display behaviours consistent with the AZ vision and values (those with line report, their team members demonstrates the same)
• Feedback from others; climate survey
• No valid complaints from competitors against marketing practice
• No breach of confidentiality. All disclosures are investigated and resolved
• No critical finding in relevant internal or regulatory authority audits

Development

Continuously demonstrate development of scientific expertise in disease area(s) of company focus

• Positive engagement and response to coaching and feedback received from line manager and TA lead.
• In daily work takes time to reflect on customer interactions and works on areas agreed with line manager as priorities for development.

• Develop behaviours leading to enhanced effectiveness as outlined in Competency definitions.
• Proactively demonstrate the AZ Values 
• Active participation in AZ training, projects, and meetings depending on development needs

Measures (QQA)

Quality

• 100% completion of  training as required on Medical Academy
• Assessment of knowledge on coaching visits and through half yearly assessment

• Has a personal development plan and completes identified development activities as planned

Education, Qualifications, Skills and Experience

Essential

• Masters degree in a scientific discipline
• Experience of Medical Affairs function within a pharmaceutical industry
• Extensive experience in relationship and stakeholder management
• Project management experience

Desirable

• Qualified Doctor
• PhD  in a scientific discipline
• Understanding of multiple aspects within Medical Affairs
• Extensive knowledge of the latest technical and regulatory developments

Key personal capabilities and attitude

Key Functional Capabilities as defined in MSL Handbook

• Excellent Communication Skills
• Good Planning and Organisational Skills
• Excellent Scientific knowledge
• Ability to develop Strategic Partnerships

Demonstrate AZ Values Consistently

• We follow the science
• We put patients first
• We play to win
• We do the right thing
• We are entrepreneurial

Key Relationships to reach solutions

Internal (to AZ or team)

• Senior Management within Brand or Disease area
• Medical Affairs Function
• Compliance Team

External (to AZ)

• Service Providers
• Regulatory bodies
• Other local and regional stakeholders
• Healthcare professionals

Date Posted

23-thg 4-2026

Closing Date

30-thg 5-2026

AstraZeneca embraces diversity and equality of opportunity.  We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills.  We believe that the more inclusive we are, the better our work will be.  We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics.  We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.